As senior expert in the field of Global Health, I focus on catalyzing innovative health solutions for most vulnerable populations such as children and their mothers in developing countries to strengthen local capacity and to foster human progress. With my background in pharmaceutical and biotech industry such as Evotec, Sanofi and Merck, I led various R&D teams from drug discovery to submission. I also created and implemented the Bioethics Advisory Panel at Merck with renowned experts from various fields of bioethics, biomedical law and religious studies. From 2017 to 2024, I have been the Head of the Merck Global Health Institute and Board Chair of the Pediatric Praziquantel Consortium, steering programs to control and eliminate schistosomiasis and malaria. Pan-African partnership networks and fundraising were key contributors to the Institute’s success. I also serve as scientific advisor at various boards, including the DZIF Scientific Advisory Board in Germany and the Cross-Pharma Capacity Development Initiative, hosted by the Science for Africa Foundation.